1-3 of 3
Lindsay Orton
Close
Sort by
Journal Articles

Efficacy and Safety of a Novel Non-Myeloablative Conditioning Regimen for Hematopoietic Cell Transplantation in Adults with Severe Aplastic Anemia

Rachel M Gilmore, Karin M Abernathy, Kendall C Shultes, Dwight D Eplin, Lindsay Orton, Adetola A. Kassim, Bipin N. Savani, Salyka M. Sengsayadeth, Brian G. Engelhardt, Wichai Chinratanalab, Tae Kon Kim, Bhagirathbhai Dholaria, Reena Jayani, Leena Choi, Elizabeth McNeer, Katie S. Gatwood
Journal: Blood
Blood (2022) 140 (Supplement 1): 2386–2388.
https://doi.org/10.1182/blood-2022-163283
Published: 2022
Journal Articles

Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Jim A. Connelly, Eden Biltibo, Karina Wilkerson, Adriana Seber, Roseane V Gouveia, Carmem Bonfim, Belinda Pinto Simões, Erfan Nur, Biljana N. Horn, Michael Eckrich, Rabi Hanna, Nathalie Dhedin, Fahed Almhareb, Mahmoud Aljurf, Hemalatha G. Rangarajan, Katie S. Gatwood, Lindsay Orton, Carrie Lynn Kitko, Mohsen Alzahrani, Ali Debsan Alahmari, Josu De La Fuente, Adetola A. Kassim
Journal: Blood
Blood (2022) 140 (Supplement 1): 10462–10464.
https://doi.org/10.1182/blood-2022-170552
Published: 2022
Journal Articles

Effective Desensitization Strategy for Patients with Sickle Cell Disease with High Donor Specific Antibodies Undergoing Haploidentical Bone Marrow Transplant with Posttransplant Cyclophosphamide

Eden Biltibo, Reena Jayani, Leena Karnik, Adam Gassas, Farah O'Boyle, Daniel Dexter, Karina Wilkerson, Katie S. Gatwood, Lindsay Orton, Bhagirathbhai Dholaria, Bipin N. Savani, Brian G. Engelhardt, Salyka M. Sengsayadeth, Carrie Lynn Kitko, James P Connelly, Adetola A. Kassim, Josu de la Fuente
Journal: Blood
Blood (2022) 140 (Supplement 1): 7613–7615.
https://doi.org/10.1182/blood-2022-162825
Published: 2022